Advances in the Polymeric Delivery of Nucleic Acid Vaccines

Overview

Journal Theranostics

Date 2022 Jun 8

PMID 35673570

Authors

Gang Chen

Bowen Zhao

Elena F Ruiz

Fuwu Zhang

Affiliations

Soon will be listed here.

Abstract

Nucleic acid vaccines, especially messenger RNA (mRNA) vaccines, display unique benefits in the current COVID-19 pandemic. The application of polymeric materials as delivery carriers has greatly promoted nucleic acid vaccine as a promising prophylactic and therapeutic strategy. The inherent properties of polymeric materials render nucleic acid vaccines with excellent in vivo stability, enhanced biosafety, specific cellular uptake, endolysosomal escape, and promoted antigen expression. Although polymeric delivery of nucleic acid vaccines has progressed significantly in the past decades, clinical translation of polymer-gene vaccine systems still faces insurmountable challenges. This review summarizes the diverse polymers and their characterizations and representative formulations for nucleic acid vaccine delivery. We also discussed existing problems, coping strategies, and prospect relevant to applications of nucleic acid vaccines and polymeric carriers. This review highlights the rational design and development of polymeric vaccine delivery systems towards meeting the goals of defending serious or emerging diseases.

Citing Articles

Global research hotspots and trends in DNA vaccine research: A bibliometric and visualization study from 2014 to 2024.

Zhang J, Zhang H, Yao C, Gu L, Dong S, Wu Y Hum Vaccin Immunother. 2025; 21(1):2457189.

PMID: 39871452 PMC: 11776459. DOI: 10.1080/21645515.2025.2457189.

-Derived β-Glucan Capsules as a Delivery System for DNA Vaccines.

Pinho S, Invencao M, Silva A, Macedo L, Espinoza B, Leal L Vaccines (Basel). 2025; 12(12.

PMID: 39772088 PMC: 11728682. DOI: 10.3390/vaccines12121428.

mRNA vaccines in the context of cancer treatment: from concept to application.

Fu Q, Zhao X, Hu J, Jiao Y, Yan Y, Pan X J Transl Med. 2025; 23(1):12.

PMID: 39762875 PMC: 11702060. DOI: 10.1186/s12967-024-06033-6.

New insights for the development of efficient DNA vaccines.

Berger S, Zeyn Y, Wagner E, Bros M Microb Biotechnol. 2024; 17(11):e70053.

PMID: 39545748 PMC: 11565620. DOI: 10.1111/1751-7915.70053.

Recent research advances in the development of Dabie Banda virus vaccines.

Yu C, Lin Y, Dai Y, Wu B, Qi Z, Qian X PLoS Negl Trop Dis. 2024; 18(8):e0012411.

PMID: 39207951 PMC: 11361446. DOI: 10.1371/journal.pntd.0012411.

References

Wafa E, Geary S, Goodman J, Narasimhan B, Salem A . The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response. Acta Biomater. 2017; 50:417-427. PMC: 5316298. DOI: 10.1016/j.actbio.2017.01.005. View

Lachelt U, Wagner E . Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond). Chem Rev. 2015; 115(19):11043-78. DOI: 10.1021/cr5006793. View

Ahmed M, Narain R . The effect of polymer architecture, composition, and molecular weight on the properties of glycopolymer-based non-viral gene delivery systems. Biomaterials. 2011; 32(22):5279-90. DOI: 10.1016/j.biomaterials.2011.03.082. View

Souci L, Jaunet H, Le Diguerher G, Guionnet J, Beven V, Paboeuf F . Intranasal inoculations of naked or PLGA-PEI nanovectored DNA vaccine induce systemic and mucosal antibodies in pigs: A feasibility study. Res Vet Sci. 2020; 132:194-201. DOI: 10.1016/j.rvsc.2020.06.018. View

Sims L, Curtis L, Frieboes H, Steinbach-Rankins J . Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer. J Nanobiotechnology. 2016; 14:33. PMC: 4840861. DOI: 10.1186/s12951-016-0185-x. View

Wang X, He Y, Wu J, Gao C, Xu Y . Synthesis and evaluation of phenylalanine-modified hyperbranched poly(amido amine)s as promising gene carriers. Biomacromolecules. 2009; 11(1):245-51. DOI: 10.1021/bm901091z. View

Karlsson J, Rhodes K, Green J, Tzeng S . Poly(beta-amino ester)s as gene delivery vehicles: challenges and opportunities. Expert Opin Drug Deliv. 2020; 17(10):1395-1410. PMC: 7658038. DOI: 10.1080/17425247.2020.1796628. View

Yin Y, Li X, Ma H, Zhang J, Yu D, Zhao R . Transforming RNA Nanovaccines from Polyethylenimine Functionalized Graphene Oxide Hydrogel for Durable Cancer Immunotherapy. Nano Lett. 2021; 21(5):2224-2231. DOI: 10.1021/acs.nanolett.0c05039. View

Nichols W, Ledwith B, Manam S, Troilo P . Potential DNA vaccine integration into host cell genome. Ann N Y Acad Sci. 1995; 772:30-9. DOI: 10.1111/j.1749-6632.1995.tb44729.x. View

10.

Gonzalez-Miro M, Rodriguez-Noda L, Farinas-Medina M, Garcia-Rivera D, Verez-Bencomo V, Rehm B . Self-assembled particulate PsaA as vaccine against infection. Heliyon. 2017; 3(4):e00291. PMC: 5390691. DOI: 10.1016/j.heliyon.2017.e00291. View

11.

Bansal A, Wu X, Olson V, DSouza M . Characterization of rabies pDNA nanoparticulate vaccine in poloxamer 407 gel. Int J Pharm. 2018; 545(1-2):318-328. DOI: 10.1016/j.ijpharm.2018.05.018. View

12.

Wibowo D, Jorritsma S, Gonzaga Z, Evert B, Chen S, Rehm B . Polymeric nanoparticle vaccines to combat emerging and pandemic threats. Biomaterials. 2020; 268:120597. PMC: 7834201. DOI: 10.1016/j.biomaterials.2020.120597. View

13.

Chen C, Yang Z, Tang X . Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy. Med Res Rev. 2018; 38(3):829-869. DOI: 10.1002/med.21479. View

14.

Huang P, Wang X, Liang X, Yang J, Zhang C, Kong D . Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy. Acta Biomater. 2018; 85:1-26. DOI: 10.1016/j.actbio.2018.12.028. View

15.

Palumbo R, Zhong X, Panus D, Han W, Ji W, Wang C . Transgene expression and local tissue distribution of naked and polymer-condensed plasmid DNA after intradermal administration in mice. J Control Release. 2012; 159(2):232-9. PMC: 3351500. DOI: 10.1016/j.jconrel.2012.01.012. View

16.

Lu B, Wang C, Wu D, Li C, Zhang X, Zhuo R . Chitosan based oligoamine polymers: synthesis, characterization, and gene delivery. J Control Release. 2009; 137(1):54-62. DOI: 10.1016/j.jconrel.2009.03.004. View

17.

Minasyan H . Phagocytosis and oxycytosis: two arms of human innate immunity. Immunol Res. 2018; 66(2):271-280. DOI: 10.1007/s12026-018-8988-5. View

18.

Yu W, Sun J, Liu F, Yu S, Xu Z, Wang F . Enhanced Immunostimulatory Activity of a Cytosine-Phosphate-Guanosine Immunomodulator by the Assembly of Polymer DNA Wires and Spheres. ACS Appl Mater Interfaces. 2020; 12(15):17167-17176. DOI: 10.1021/acsami.9b21075. View

19.

Kutzler M, Weiner D . DNA vaccines: ready for prime time?. Nat Rev Genet. 2008; 9(10):776-88. PMC: 4317294. DOI: 10.1038/nrg2432. View

20.

Lee P, Hsu S, Tsai J, Chen F, Huang P, Ke C . Multifunctional core-shell polymeric nanoparticles for transdermal DNA delivery and epidermal Langerhans cells tracking. Biomaterials. 2009; 31(8):2425-34. DOI: 10.1016/j.biomaterials.2009.11.100. View